港股异动 | 三叶草生物-B(02197)再涨超7% 获四价流感疫苗独家分销协议

智通财经2023-02-22

智通财经APP获悉，三叶草生物-B(02197)再涨超7%，截至发稿，涨4.23%，报2.71港元，成交额3493.52万港元。消息面上，三叶草生物近日发布公告称，公司与国光生物科技股份有限公司达成AdimFlu-S在中国分销的独家协议。该款产品是国内唯一获批用于三岁及以上人群的进口四价季节性流感疫苗。该独家协议还授权三叶草生物获得注册部门批准后，在孟加拉国、巴西和菲律宾商业化AdimFlu-S(...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2313406962?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-02-22 09:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2313406962","market":"us","top_or_hot":-1,"title":"港股异动 | 三叶草生物-B(02197)再涨超7% 获四价流感疫苗独家分销协议","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，三叶草生物-B(02197)再涨超7%，截至发稿，涨4.23%，报2.71港元，成交额3493.52万港元。消息面上，三叶草生物近日发布公告称，公司与国光生物科技股份有限公司达成AdimFlu-S在中国分销的独家协议。该款产品是国内唯一获批用于三岁及以上人群的进口四价季节性流感疫苗。该独家协议还授权三叶草生物获得注册部门批准后，在孟加拉国、巴西和菲律宾商业化AdimFlu-S(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/880258.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 三叶草生物-B(02197)再涨超7% 获四价流感疫苗独家分销协议</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 三叶草生物-B(02197)再涨超7% 获四价流感疫苗独家分销协议\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-22 09:46 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/880258.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，三叶草生物-B(02197)再涨超7%，截至发稿，涨4.23%，报2.71港元，成交额3493.52万港元。消息面上，三叶草生物近日发布公告称，公司与国光生物科技股份有限公司达成AdimFlu-S在中国分销的独家协议。该款产品是国内唯一获批用于三岁及以上人群的进口四价季节性流感疫苗。该独家协议还授权三叶草生物获得注册部门批准后，在孟加拉国、巴西和菲律宾商业化AdimFlu-S(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/880258.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/880258.html","article_id":"2313406962","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2313406962","pubTimestamp":1677030416,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，三叶草生物-B再涨超7%，截至发稿，涨4.23%，报2.71港元，成交额3493.52万港元。消息面上，三叶草生物近日发布公告称，公司与国光生物科技股份有限公司达成AdimFlu-S在中国分销的独家协议。该款产品是国内唯一获批用于三岁及以上人群的进口四价季节性流感疫苗。该独家协议还授权三叶草生物获得注册部门批准后，在孟加拉国、巴西和菲律宾商业化AdimFlu-S，并有望与国光生技合作开发其他候选疫苗，包括下一代流感疫苗。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","02197":"三叶草生物-B"},"translate_title":"Hong Kong stocks changed Clover Bio-B (02197) rose by more than 7% and won the exclusive distribution agreement of tetravalent influenza vaccine","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02197":1},"content_text":"智通财经APP获悉，三叶草生物-B(02197)再涨超7%，截至发稿，涨4.23%，报2.71港元，成交额3493.52万港元。消息面上，三叶草生物近日发布公告称，公司与国光生物科技股份有限公司达成AdimFlu-S在中国分销的独家协议。该款产品是国内唯一获批用于三岁及以上人群的进口四价季节性流感疫苗。该独家协议还授权三叶草生物获得注册部门批准后，在孟加拉国、巴西和菲律宾商业化AdimFlu-S(QIS)，并有望与国光生技合作开发其他候选疫苗，包括下一代流感疫苗。公司指出，在不断增长且稳定的流感疫苗市场中，有关交易预计将在2023年对公司的财务状况带来增量，并在2024年及以后创造具有意义的增长。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2313406962"}